Mene Pangalos, Executive Vice President, Biopharmaceutical R&D at AstraZeneca, said: “With different variants threatening to disrupt our exit from the pandemic, this concrete evidence shows that the vaccine, as well as other vaccines used in Canada, offer a level protection against the most severe forms of the disease, even after a single injection.
“It is essential that we continue to protect as many people as possible in all corners of the world in order to stay ahead of this deadly virus. “
In February, South Africa halted deployment of the AstraZeneca jab after testing showed the beta variant virtually wiped out any advantage. However, critics pointed out that the trial subjects were young and healthy, making it impossible to assess its effectiveness against serious disease.
New data from 421,073 Canadians show that the vaccine provided “good to excellent protection against symptomatic infections and serious outcomes” even after a single dose.
The research will make it harder for the UK government to justify the current restrictions on travelers from France.
Last week, Grant Shapps, the Secretary of Transportation, defended the ‘amber plus’ designation and said,’ We don’t want to go that far with vaccinations and then throw it all away because a variant that the vaccine can’t. -be not manage entered. “
However, he said the latest research into the efficacy of the beta variant vaccine was “constantly being reviewed.”
Beta variant cases have declined considerably in France in recent weeks as the delta variant has taken hold and now represents only 1.9% of all infections.
Jean-Yves Le Drian, French Minister for Europe, said there was no reason to keep the country on the “amber plus” list. The list of UK traffic light trips will be updated on Thursday, when France is expected to be lowered to the color orange.